NEURAL INSIGHTS FOR PRECISION MEDICINE
BIOS THERAPY DEVELOPMENT PLATFORM
BIOS’ Therapy Development Platform transforms neural and physiological signals into neural biomarkers. Neural biomarkers provide real-time insights into the nervous system, improving the precision and responsiveness of bioelectronic and molecular therapies for a wide range of chronic diseases.
The platform consists of four systems that work together to encompass every step of therapy development from discovery and design to delivery and commercialisation.
PRECLINICAL
DISCOVERY SYSTEM
INFRASTRUCTURE FOR NEURAL AND PHYSIOLOGY DATA INGESTION, ANALYSIS AND MODELLING
DATA DRIVEN DISCOVERY
Validated, modular hardware and software suite for acute and long-term preclinical studies including neural interface and physiology data acquisition systems
High-fidelity, high-resolution visualisation of neural and physiological data in real-time
Measures nerve fibre activation to predict therapeutic and off-target effects
Rapid exploration of stimulation parameters and dosing reduces discovery costs and accelerates lead candidate identification
Custom biomarkers for precision dosing of neuromodulation and molecular therapies
OUR INVESTORS
POWERING CLINICAL TRIALS & NEURAL DATA DISCOVERY
UK Partners
Clinical base and
R&D Headquarters
Cambridge
Pre-clinical base
North America R&D
Montreal & Minnesota
Top Co
San Francisco
Global Partners
THE BIOS TEAM
The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ First of kind medical devices and 6k+ clinical procedures. To achieve this, we are bringing together the best and brightest from a variety of fields: from neuroscience, machine learning and AI, hardware and software engineering, and medicine to operations, finance, business development, and communications. Previous staff companies include:
